Exercise reduces systemic immune inflammation index (SII) in childhood cancer patients

Support Care Cancer. 2022 Apr;30(4):2905-2908. doi: 10.1007/s00520-021-06719-3. Epub 2021 Dec 3.

Abstract

While exercise and physical activity have been suggested to reduce mortality and symptoms in cancer, knowledge on these associations in patients with childhood cancer (CCPs) is sparse. Anti-inflammatory properties of exercise might mediate these beneficial effects. We investigated the influence of exercise on the inflammation markers neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic-immune-inflammation index (SII) and associations to patient-reported-outcomes in CCPs in a randomized-controlled trial. Results show associations between inflammation markers and patient-reported outcomes. Compared to the control group, SII was significantly reduced following exercise (p=0.036). Anti-inflammatory effects of exercise are also present in CCPs and may underlie exercise-induced benefits on symptoms. Clinical Trial Registration Number: NCT02612025.

Keywords: Cellular inflammation; Endurance training; Pediatric oncology; Resistance training; Tumor entities.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Child
  • Exercise
  • Humans
  • Inflammation
  • Lymphocytes
  • Neoplasms* / therapy
  • Neutrophils
  • Prognosis
  • Retrospective Studies

Associated data

  • ClinicalTrials.gov/NCT02612025